| EPB0115 | HIV-1 Low level viremia predicts virological failure in first-line and second-line ART experienced individuals in India | E-poster | Diagnostic and monitoring tools |
| TUPEA04 | HIV-1 infection: virus and host wrestle for control of the SUMOylation system | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
| TUPEB20 | HIV viral suppression and drug resistance patterns among adults and children in the era of dolutegravir use: Findings from the national representative cross-sectional survey in Tanzania | Poster exhibition | ART resistance |
| EPA0049 | HIV vaccine candidate efficacy mediated by epigenetic changes in CD14+ cells and cAMP-dependent efferocytosis | E-poster | Host immune responses, vaccines and immunotherapies |
| TUPEC19 | HIV treatment outcomes among people who inject drugs: a global systematic review and meta-analysis | Poster exhibition | Cascades of HIV care and treatment |
| EPB0206 | HIV treatment outcomes after 10 years on ART in the TREAT Asia Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) | E-poster | Antiretroviral therapies and clinical issues in adults |
| LBEPC21 | HIV transmission clusters in Zambia are smaller than in Europe: evidence from the HPTN-071 (PopART) study, BEEHIVE study, and individual-based models | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0422 | HIV testing, prevention, treatment and medication-assisted therapy achievements for people who inject drugs in CDC/PEPFAR-supported countries, 2021-2022 | E-poster | Population-specific interventions for HIV prevention |
| EPD0596 | HIV stigma, mental health and substance use in transgender women with HIV: results of the first year of follow-up in the TransCITAR cohort | E-poster | Social and behavioural aspects and approaches to HIV |
| EPC0382 | HIV seroconversion in PrEP users in Indonesia; a survival analysis | E-poster | HIV prevention research |